| Primary |
| Schizophrenia |
47.5% |
| Anxiety |
6.7% |
| Insomnia |
6.4% |
| Schizoaffective Disorder |
4.6% |
| Prophylaxis |
4.5% |
| Schizophrenia, Paranoid Type |
4.3% |
| Product Used For Unknown Indication |
3.8% |
| Depression |
3.4% |
| Atopy |
2.6% |
| Gastritis |
2.5% |
| Psychotic Disorder |
1.8% |
| Agitation |
1.7% |
| Hypertension |
1.4% |
| Constipation |
1.3% |
| Drug Abuse |
1.3% |
| Drug Therapy |
1.3% |
| Sleep Disorder |
1.3% |
| Drug Use For Unknown Indication |
1.2% |
| Sedation |
1.2% |
| Tension |
1.2% |
|
| Schizophrenia |
27.8% |
| Psychotic Disorder |
20.6% |
| Suicidal Ideation |
9.4% |
| Suicide Attempt |
7.2% |
| Anxiety |
6.1% |
| Depression |
3.9% |
| Aspartate Aminotransferase Increased |
3.3% |
| Delirium |
2.2% |
| Intentional Self-injury |
2.2% |
| Schizophrenia, Paranoid Type |
2.2% |
| Tremor |
2.2% |
| Deep Vein Thrombosis |
1.7% |
| Delusion |
1.7% |
| Depression Suicidal |
1.7% |
| Vomiting |
1.7% |
| Weight Increased |
1.7% |
| Acute Psychosis |
1.1% |
| Completed Suicide |
1.1% |
| Contusion |
1.1% |
| Dyspnoea |
1.1% |
|
| Secondary |
| Schizophrenia |
46.4% |
| Anxiety |
7.0% |
| Insomnia |
5.8% |
| Schizophrenia, Paranoid Type |
5.1% |
| Schizoaffective Disorder |
5.0% |
| Lower Limb Fracture |
4.0% |
| Product Used For Unknown Indication |
3.3% |
| Constipation |
3.0% |
| Depression |
2.9% |
| Psychotic Disorder |
2.8% |
| Cellulitis |
2.0% |
| Agitation |
1.8% |
| Atopy |
1.7% |
| Gastritis |
1.7% |
| Irritability |
1.5% |
| Wheezing |
1.5% |
| Hypertension |
1.3% |
| Drug Therapy |
1.1% |
| Sleep Disorder |
1.0% |
| Suicide Attempt |
1.0% |
|
| Schizophrenia |
30.5% |
| Psychotic Disorder |
18.1% |
| Suicidal Ideation |
10.6% |
| Suicide Attempt |
4.9% |
| Depression |
4.4% |
| Anxiety |
4.0% |
| Acute Psychosis |
3.1% |
| Psychiatric Symptom |
3.1% |
| Vomiting |
3.1% |
| Aggression |
2.7% |
| Restlessness |
1.8% |
| Syncope |
1.8% |
| Tension |
1.8% |
| Tremor |
1.8% |
| Weight Increased |
1.8% |
| Deep Vein Thrombosis |
1.3% |
| Depression Suicidal |
1.3% |
| Dyskinesia |
1.3% |
| Haematemesis |
1.3% |
| Inappropriate Schedule Of Drug Administration |
1.3% |
|
| Concomitant |
| Schizophrenia, Disorganised Type |
23.5% |
| Product Used For Unknown Indication |
17.6% |
| Schizoid Personality Disorder |
15.7% |
| Bipolar Disorder |
9.8% |
| Schizoaffective Disorder |
7.8% |
| Abdominal Discomfort |
3.9% |
| Anxiety |
3.9% |
| Off Label Use |
3.9% |
| Osteopenia |
3.9% |
| Schizophrenia, Paranoid Type |
3.9% |
| Drug Use For Unknown Indication |
2.0% |
| Narcolepsy |
2.0% |
| Schizophrenia |
2.0% |
|
| Suicidal Ideation |
31.6% |
| Pruritus |
21.1% |
| Thinking Abnormal |
10.5% |
| Weight Decreased |
10.5% |
| Psychotic Disorder |
5.3% |
| Pulmonary Embolism |
5.3% |
| Thrombocytopenia |
5.3% |
| White Blood Cell Count Abnormal |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Hyperprolactinaemia |
100.0% |
|
